Use of Thermal and 3D Imaging to Quantify Arthritis

Rheumatoid Arthritis Clinical Trial

Official title:

Use of Thermal and 3D Imaging to Quantify Arthritis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01044823
• Other study ID #: PRO08040135
• Secondary ID: R21AR056690
• Status: Completed
• Phase: N/A
• First received: January 6, 2010
• Last updated: July 26, 2017
• Start date: January 2010
• Est. completion date: January 2014

Study information

• Verified date: February 2011
• Source: University of Pittsburgh
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

One of the biggest challenges in caring for patients with Rheumatoid Arthritis (RA) and Juvenile Rheumatoid Arthritis (JRA) is quantifying the degree of disease activity in any given joint. We have built a prototype device using well-established sensors to rapidly quantify surface swelling and heat in arthritic joints. The goal of our studies is to test the hypothesis that this Imager can improve the clinical assessment of arthritis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 157
• Est. completion date: January 2014
• Est. primary completion date: March 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 4 Years and older

Eligibility

Inclusion Criteria:

• at least 4 years of age

Exclusion Criteria:

• less than 4 years of age

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Juvenile
• Arthritis, Rheumatoid
• Juvenile Rheumatoid Arthritis
• Rheumatoid Arthritis

Intervention

Other:
• 3D and thermal imaging
subjects will be imaged before and after receiving DMARD therapy

Locations

Country	Name	City	State
United States	University of Pittsburgh	Pittsburgh	Pennsylvania

Sponsors (2)

Lead Sponsor	Collaborator
University of Pittsburgh	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Country where clinical trial is conducted

United States,